Carmen Alvarez1,2, Anika L Hines3, Kathryn A Carson2,4, Nadia Andrade1, Chidinma A Ibe2,4, Jill A Marsteller5, Lisa A Cooper1,2,4,6. 1. Johns Hopkins University School of Nursing, Baltimore, MD. 2. Johns Hopkins Center for Health Equity, Baltimore, MD. 3. Virginia Commonwealth University School of Medicine, Department of Health Behavior and Policy, Richmond, VA. 4. Johns Hopkins University School of Medicine, Department of Medicine, Division of General Internal Medicine, Baltimore, MD. 5. Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management, Baltimore, MD. 6. Johns Hopkins Bloomberg School of Public Health, Department of Health, Behavior and Society, Baltimore, MD.
Abstract
Background: Uncontrolled hypertension is a significant risk factor for cardiovascular morbidity and mortality. In the United States, many patients remain uncontrolled, in part, due to poor medication adherence. Efforts to improve hypertension control include not only attending to medical management of the disease but also the social determinants of health, which impact medication adherence, and ultimately blood pressure control. Purpose: To determine which social determinants - health care access or community and social stressors - explain medication adherence. Methods: In this cross-sectional analysis, we used baseline data (N=1820, collected August 2017 to October 2019) from a pragmatic trial, which compares the effectiveness of a multi-level intervention including collaborative care and a stepped approach with enhanced standard of care for improving blood pressure. We used logistic regression analyses to examine the association between patient experiences of care and community and social stressors with medication adherence. Results: The participants represented a diverse sample: mean age of 60 years; 59% female; 57.3% Black, 9.6% Hispanic, and 33.2% White. All participants had a blood pressure reading ≥140/90 mm Hg (mean blood pressure - 152/85 mm Hg). Half of the participants reported some level of non-adherence to medication. Regression analysis showed that, compared with Whites, Blacks (AOR .47; 95% CIs: .37-.60, P<.001) and Hispanics (AOR .48; 95% CIs: .32- .73, P<.001) were less likely to report medication adherence. Also part-time workers (AOR .57; 95% CIs: .38-.86, P<.05), and those who reported greater perceived stress (AOR .94; 95% CIs: .91 - .98, P<.001) and everyday discrimination (AOR .73; 95% CIs: .59 - .89; P<.001) had lower odds of medication adherence. Among Blacks, greater perceived stress (AOR .93; 95% CIs: .88-.98, P<.001) and everyday discrimination (AOR .63; 95% CIs: .49 - .82, P<.005) were negatively associated with medication adherence. Among Hispanics, greater report of everyday discrimination (AOR .36; 95% CIs: .14 - .89, P<.005) was associated with lower odds of medication adherence. Among Whites, the negative effect of perceived stress on medication adherence was attenuated by emotional support. Conclusions: Using the social determinants of health framework, we identified associations between stress, everyday discrimination and medication adherence among non-Hispanic Blacks and Hispanics that were independent of health status and other social determinants. Programs to enhance self-management for African American and Hispanic patients with uncontrolled blood pressure should include a specific focus on addressing social stressors.
Background: Uncontrolled hypertension is a significant risk factor for cardiovascular morbidity and mortality. In the United States, many patients remain uncontrolled, in part, due to poor medication adherence. Efforts to improve hypertension control include not only attending to medical management of the disease but also the social determinants of health, which impact medication adherence, and ultimately blood pressure control. Purpose: To determine which social determinants - health care access or community and social stressors - explain medication adherence. Methods: In this cross-sectional analysis, we used baseline data (N=1820, collected August 2017 to October 2019) from a pragmatic trial, which compares the effectiveness of a multi-level intervention including collaborative care and a stepped approach with enhanced standard of care for improving blood pressure. We used logistic regression analyses to examine the association between patient experiences of care and community and social stressors with medication adherence. Results: The participants represented a diverse sample: mean age of 60 years; 59% female; 57.3% Black, 9.6% Hispanic, and 33.2% White. All participants had a blood pressure reading ≥140/90 mm Hg (mean blood pressure - 152/85 mm Hg). Half of the participants reported some level of non-adherence to medication. Regression analysis showed that, compared with Whites, Blacks (AOR .47; 95% CIs: .37-.60, P<.001) and Hispanics (AOR .48; 95% CIs: .32- .73, P<.001) were less likely to report medication adherence. Also part-time workers (AOR .57; 95% CIs: .38-.86, P<.05), and those who reported greater perceived stress (AOR .94; 95% CIs: .91 - .98, P<.001) and everyday discrimination (AOR .73; 95% CIs: .59 - .89; P<.001) had lower odds of medication adherence. Among Blacks, greater perceived stress (AOR .93; 95% CIs: .88-.98, P<.001) and everyday discrimination (AOR .63; 95% CIs: .49 - .82, P<.005) were negatively associated with medication adherence. Among Hispanics, greater report of everyday discrimination (AOR .36; 95% CIs: .14 - .89, P<.005) was associated with lower odds of medication adherence. Among Whites, the negative effect of perceived stress on medication adherence was attenuated by emotional support. Conclusions: Using the social determinants of health framework, we identified associations between stress, everyday discrimination and medication adherence among non-Hispanic Blacks and Hispanics that were independent of health status and other social determinants. Programs to enhance self-management for African American and Hispanic patients with uncontrolled blood pressure should include a specific focus on addressing social stressors.
Authors: Lisa A Cooper; Jill A Marsteller; Kathryn A Carson; Katherine B Dietz; Romsai T Boonyasai; Carmen Alvarez; Chidinma A Ibe; Deidra C Crews; Hsin-Chieh Yeh; Edgar R Miller; Cheryl R Dennison-Himmelfarb; Lisa H Lubomski; Tanjala S Purnell; Felicia Hill-Briggs; Nae-Yuh Wang Journal: Am Heart J Date: 2020-05-08 Impact factor: 4.749
Authors: Yendelela L Cuffee; J Lee Hargraves; Milagros Rosal; Becky A Briesacher; Antoinette Schoenthaler; Sharina Person; Sandral Hullett; Jeroan Allison Journal: Am J Public Health Date: 2013-09-12 Impact factor: 9.308
Authors: Elizabeth A Hahn; Robert F Devellis; Rita K Bode; Sofia F Garcia; Liana D Castel; Susan V Eisen; Hayden B Bosworth; Allen W Heinemann; Nan Rothrock; David Cella Journal: Qual Life Res Date: 2010-04-25 Impact factor: 4.147
Authors: Gbenga Ogedegbe; William Chaplin; Antoinette Schoenthaler; David Statman; David Berger; Tabia Richardson; Erica Phillips; Jacqueline Spencer; John P Allegrante Journal: Am J Hypertens Date: 2008-07-24 Impact factor: 2.689
Authors: Peter K Yang; Matthew D Ritchey; Stavros Tsipas; Fleetwood Loustalot; Gregory D Wozniak Journal: Prev Chronic Dis Date: 2020-09-24 Impact factor: 2.830